{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:14:00Z","timestamp":1779084840359,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,18]]},"DOI":"10.7759\/cureus.14542","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T11:43:07Z","timestamp":1618746187000},"source":"Crossref","is-referenced-by-count":6,"title":["Male Triple-Negative Breast Cancer"],"prefix":"10.7759","author":[{"given":"Qasif","family":"Qavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Alkistawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizwan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdalla","family":"Saad Abdalla Al-Zawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4921-9","article-title":"Male breast cancer: a disease distinct from female breast cancer","volume":"173","author":"Gucalp A","year":"2019","unstructured":"Gucalp A, Traina TA, Eisner JR, et al.. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat. 2019, 173:37-48. 10.1007\/s10549-018-4921-9","journal-title":"Breast Cancer Res Treat"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68226-3","article-title":"Male breast cancer","volume":"367","author":"Fentiman IS","year":"2006","unstructured":"Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006, 367:595-604. 10.1016\/S0140-6736(06)68226-3","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2258","article-title":"Immunohistochemical characterization of subtypes of male breast carcinoma","volume":"11","author":"Ge Y","year":"2009","unstructured":"Ge Y, Sneige N, Eltorky MA, Wang Z, Lin E, Gong Y, Guo M. Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Res. 2009, 11:28. 10.1186\/bcr2258","journal-title":"Breast Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14445\/23939117\/IJMS-V7I11P101","article-title":"Ki -67 proliferative index as a predictive tool for axillary pathological complete response in node-positive breast cancer","volume":"7","author":"Saad Abdalla Al-Zawi A","year":"2020","unstructured":"Saad Abdalla Al-Zawi A. Ki -67 proliferative index as a predictive tool for axillary pathological complete response in node-positive breast cancer. SSRG Int J Med Sci. 2020, 7:1-4. 10.14445\/23939117\/IJMS-V7I11P101","journal-title":"SSRG Int J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5152\/tjbh.2015.2711","article-title":"Male breast cancer","volume":"12","author":"Yalaza M","year":"2016","unstructured":"Yalaza M, \u0130nan A, Bozer M. Male breast cancer. J Breast Health. 2016, 12:1-8. 10.5152\/tjbh.2015.2711","journal-title":"J Breast Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003299","article-title":"Characterization of Korean male breast cancer using an online nationwide breast-cancer database: matched-pair analysis of patients with female breast cancer","volume":"95","author":"Choi MY","year":"2016","unstructured":"Choi MY, Lee SK, Lee JE, et al.. Characterization of Korean male breast cancer using an online nationwide breast-cancer database: matched-pair analysis of patients with female breast cancer. Medicine (Baltimore). 2016, 95:3299. 10.1097\/MD.0000000000003299","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2014.08.004","article-title":"Breast cancer in male-to-female transgender patients: a case for caution","volume":"15","author":"Sattari M","year":"2015","unstructured":"Sattari M. Breast cancer in male-to-female transgender patients: a case for caution. Clin Breast Cancer. 2015, 15:67-9. 10.1016\/j.clbc.2014.08.004","journal-title":"Clin Breast Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-229482","article-title":"Male occult triple-negative breast cancer","volume":"12","author":"Alsayed B","year":"2019","unstructured":"Alsayed B, Abdulla HA, Alaskar H, Dhaif A. Male occult triple-negative breast cancer. BMJ Case Rep. 2019, 12:229482. 10.1136\/bcr-2019-229482","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn329","article-title":"Prospective evaluation of risk factors for male breast cancer","volume":"100","author":"Brinton LA","year":"2008","unstructured":"Brinton LA, Richesson DA, Gierach GL, Lacey JV Jr, Park Y, Hollenbeck AR, Schatzkin A. Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst. 2008, 100:1477-81. 10.1093\/jnci\/djn329","journal-title":"J Natl Cancer Inst"},{"key":"ref10","article-title":"The importance of BRCA1 and BRCA2 genes mutations in breast cancer development","volume":"30","author":"Mehrgou A","year":"2016","unstructured":"Mehrgou A, Akouchekian M. The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Med J Islam Repub Iran. 2016, 30:484-95.","journal-title":"Med J Islam Repub Iran"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4098-y","article-title":"Male BRCA mutation carriers: clinical characteristics and cancer spectrum","volume":"18","author":"Ibrahim M","year":"2018","unstructured":"Ibrahim M, Yadav S, Ogunleye F, Zakalik D. Male BRCA mutation carriers: clinical characteristics and cancer spectrum. BMC Cancer. 2018, 18:179. 10.1186\/s12885-018-4098-y","journal-title":"BMC Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S151260","article-title":"Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature","volume":"10","author":"Zhang L","year":"2017","unstructured":"Zhang L, Zhang C, Yang Z, He M, Zhang L, Ezzat S, Liang X. Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature. Onco Targets Ther. 2017, 10:5459-62. 10.2147\/OTT.S151260","journal-title":"Onco Targets Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpdhp.2019.01.004","article-title":"Pathology of the male breast","volume":"25","author":"Shaaban AM","year":"2019","unstructured":"Shaaban AM. Pathology of the male breast. Diagn Histopathol. 2019, 25:138-42. 10.1016\/j.mpdhp.2019.01.004","journal-title":"Diagn Histopathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4382606","article-title":"A review of the hereditary component of triple negative breast cancer: high- and moderate-penetrance breast cancer genes, low-penetrance loci, and the role of nontraditional genetic elements","volume":"2019","author":"Ellsworth DL","year":"2019","unstructured":"Ellsworth DL, Turner CE, Ellsworth RE. A review of the hereditary component of triple negative breast cancer: high- and moderate-penetrance breast cancer genes, low-penetrance loci, and the role of nontraditional genetic elements. J Oncol. 2019, 2019:4382606. 10.1155\/2019\/4382606","journal-title":"J Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.36106\/paripex","article-title":"Ki67 Proliferation index as a prognostic and predictive tool for pathological response after upfront chemotherapy in breast cancer","volume":"9","author":"Saad Abdalla Al-Zawi A","year":"2020","unstructured":"Saad Abdalla Al-Zawi A, Syed A. Ki67 Proliferation index as a prognostic and predictive tool for pathological response after upfront chemotherapy in breast cancer. Paripex Indian J Res. 2020, 9:33-4. 10.36106\/paripex","journal-title":"Paripex Indian J Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27905","article-title":"Male breast cancer according to tumor subtype and race: a population-based study","volume":"119","author":"Chavez-Macgregor M","year":"2013","unstructured":"Chavez-Macgregor M, Clarke CA, Lichtensztajn D, Hortobagyi GN, Giordano SH. Male breast cancer according to tumor subtype and race: a population-based study. Cancer. 2013, 119:1611-7. 10.1002\/cncr.27905","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-011-9978-9","article-title":"Outcome of non-metastatic male breast cancer: 118 patients","volume":"29","author":"Arslan UY","year":"2012","unstructured":"Arslan UY, Oks\u00fczo\u011flu B, Ozdemir N, et al.. Outcome of non-metastatic male breast cancer: 118 patients. Med Oncol. 2012, 29:554-60. 10.1007\/s12032-011-9978-9","journal-title":"Med Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2016.11.030","article-title":"Male breast cancer: modified radical mastectomy or breast conservation surgery? A case report and review of the literature","volume":"30","author":"Giunta G","year":"2017","unstructured":"Giunta G, Rossi M, Toia F, Rinaldi G, Cordova A. Male breast cancer: modified radical mastectomy or breast conservation surgery? A case report and review of the literature. Int J Surg Case Rep. 2017, 30:89-92. 10.1016\/j.ijscr.2016.11.030","journal-title":"Int J Surg Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004614","article-title":"Features of triple-negative breast cancer: analysis of 38,813 cases from the national cancer database","volume":"95","author":"Plasilova ML","year":"2016","unstructured":"Plasilova ML, Hayse B, Killelea BK, Horowitz NR, Chagpar AB, Lannin DR. Features of triple-negative breast cancer: analysis of 38,813 cases from the national cancer database. Medicine (Baltimore). 2016, 95:4614. 10.1097\/MD.0000000000004614","journal-title":"Medicine (Baltimore)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.01.006","article-title":"Impact of adjuvant radiation therapy in patients with male breast cancer: a multicenter international analysis","volume":"5","author":"Rolf D","year":"2020","unstructured":"Rolf D, Elsayad K, Meheissen MAM, et al.. Impact of adjuvant radiation therapy in patients with male breast cancer: a multicenter international analysis. Adv Radiat Oncol. 2020, 5:345-9. 10.1016\/j.adro.2020.01.006","journal-title":"Adv Radiat Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/47133-male-triple-negative-breast-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:15Z","timestamp":1707507135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/47133-male-triple-negative-breast-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.14542","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,18]]}}}